Bio-Therapeutic Impact Award
This grant funds clinical trials of innovative biologic therapies, like immunotherapy and gene therapy, to advance new treatments for childhood cancer.
Funder: Alex's Lemonade Stand Foundation
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Up to $1.8 million total over three years per award
Summary: Supports investigators launching clinical trials of innovative biologic therapies to treat childhood cancer.
Description
The Bio-Therapeutic Impact Award from Alex's Lemonade Stand Foundation aims to accelerate the development and launch of clinical trials for promising biologic approaches in pediatric oncology. The program specifically targets innovative therapies such as immunotherapy, gene therapy, and small molecules, with the goal of advancing these treatments from the laboratory into clinical settings for childhood cancer patients. This grant encourages established investigators to pursue high-impact, translational research that may not have received NIH funding but holds significant promise for breakthroughs in childhood cancer care.
